Stock analysis for Alaunos Therapeutics Inc (ZIOP:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Jan 26, 2022 · HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced that it will report... • Over …

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address …

2 days ago · Should You Buy or Sell ZIOPHARM Oncology Stock? Get The Latest ZIOP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

Aug 5, 2025 · ZIOP stood for ZIOPHARM Oncology, a clinical-stage biopharmaceutical company focused on developing personalized, gene-modified T-cell therapies to treat solid tumors.

View ZIOPHARM Oncology (ZIOP) stock price, news, historical charts, analyst ratings, and quotes on Tiger Brokers' website. Trade with advanced market insights on Tiger Trade app.

Welcome to the overview page for ZIOP (ZIOP), where you can find comprehensive stock information and company updates. Explore the latest news on strategic partnerships, quarterly …

ZIOPHARM Oncology Inc Common Stock (ZIOP) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

Jan 26, 2022 · Ziopharm Ocology Inc (NASDAQ: ZIOP) has rebranded itself and has changed its name to Alaunos Therapeutics Inc. The Company will trade on NASDAQ under the new ticker …

ZIOPHARM Oncology stock quote and ZIOP charts. Latest stock price today and the US' most active stock market forums.